in Each Extended-Release Bi-Layer Tablet: Active Ingredients: Guaifenesin (600 mg), Expectorant; Pseudoephedrine HCI (60 mg), Nasal Decongestant. Inactive Ingredients: Carbomer Homopolymer Type B, FD&C Yellow #6 Aluminum Lake, Hypromellose, USP, Magnesium Stearate, NF, Microcrystalline Cellulose, NF, Sodium Starch Glycolate, NF.
in Each Extended-Release Bi-Layer Tablet: Directions: Do not crush, chew, or break tablet. Take with a full glass of water. This product can be administered without regard for timing meals. Adults and Children 12 Years and Older:: 2 tablets every 12 hours; not more than 4 tablets in 24 hours. Children Under 12 Years of Age:: Do not use.
in Each Extended-Release Bi-Layer Tablet: Warnings: Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drugs contains an MAOI, ask a doctor or pharmacist before taking this product. Ask a doctor before use if you have: heart disease ; high blood pressure ; thyroid disease; diabetes; trouble urinating due to an enlarged prostate gland ; persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema ; cough accompanied by too much phlegm (mucus) When using this product: do not use more than directed Stop use and ask a doctor if: you get nervous, dizzy, or sleepless; symptoms do not get better within 7 days, come back or occur with a fever, rash, or persistent headache. These could be signs of a serious illness. If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Tamper evident: Do not use if carton is open or if printed seal on blister is broken or missing.
Our website uses cookies and other technologies to help it function and give you the best Wegmans experience. For more information, see our Privacy Policy. By accessing or using our website, you agree to our updated Terms & Conditions.
